Scott E. Glaser, MD, is co-founder and president of the Pain Specialists of Greater Chicago, based in Burr Ridge, Ill. For more than 10 years, Dr. Glaser and co-founder Ira J. Goodman, MD, have provided comprehensive and minimally invasive treatment of pain, including radiofrequency treatments, selective nerve blocks, spinal cord stimulation and nucleoplasty.
In addition to presiding over the Pain Specialists of Greater Chicago, Dr. Glaser has served in key leadership roles in the pain management industry, including two stints as a director on the national board of the American Society of Interventional Pain Physicians in 2007 and 2009. He also served two terms as the president and another two terms as vice president of the Illinois Society of Interventional Pain Physicians, a local chapter of ASIPP. Dr. Glaser is also a diplomate of the American Board of Interventional Pain Physicians, an examiner for ABIPP and a fellow of Interventional Pain Practice.
Dr. Glaser played a fundamental role in the passage of the NASPER bill, which is designed to protect patients and physicians from substance misuse through prescription monitoring programs. While the bill was signed into law 2005, Dr. Glaser continues to work with state leaders on implementing a prescription monitoring system in Illinois.
"Narcotics aren't good or bad; they're a treatment option with risks that need to be appreciated, communicated, and dealt with," he said in a recent Becker's ASC Review interview. "They're not inherently evil, and doctors who prescribe them aren't evil. For some folks, they're life savers. It enhances their quality of life without adverse side effects. It's easy to lose sight of that fact in the pandemonium surrounding the epidemic of prescription drug abuse."
Dr. Glaser completed his medical education at Indiana University School of Medicine and his anesthesia residency and fellowship at Northwestern University Medical School in Chicago. His research, which has been published in the journal Pain, focuses on standard of care for lumbar and thoracic transforaminal epidural steroid injections.
In addition to presiding over the Pain Specialists of Greater Chicago, Dr. Glaser has served in key leadership roles in the pain management industry, including two stints as a director on the national board of the American Society of Interventional Pain Physicians in 2007 and 2009. He also served two terms as the president and another two terms as vice president of the Illinois Society of Interventional Pain Physicians, a local chapter of ASIPP. Dr. Glaser is also a diplomate of the American Board of Interventional Pain Physicians, an examiner for ABIPP and a fellow of Interventional Pain Practice. Dr. Glaser played a fundamental role in the passage of the NASPER bill, which is designed to protect patients and physicians from substance misuse through prescription monitoring programs. While the bill was signed into law 2005, Dr. Glaser continues to work with state leaders on implementing a prescription monitoring system in Illinois.
"Narcotics aren't good or bad; they're a treatment option with risks that need to be appreciated, communicated, and dealt with," he said in a recent Becker's ASC Review interview. "They're not inherently evil, and doctors who prescribe them aren't evil. For some folks, they're life savers. It enhances their quality of life without adverse side effects. It's easy to lose sight of that fact in the pandemonium surrounding the epidemic of prescription drug abuse."
Dr. Glaser completed his medical education at Indiana University School of Medicine and his anesthesia residency and fellowship at Northwestern University Medical School in Chicago. His research, which has been published in the journal Pain, focuses on standard of care for lumbar and thoracic transforaminal epidural steroid injections.